Prognostic significance of p16INK4a immunocytochemistry in adult ALL with standard risk karyotype

Leukemia

Volumn 15, Issue 7, 2001, Pages 1054-1059

  Soenen, V ^a,b   Lepelley, P ^a,b   Gyan, E ^a,b   Preudhomme, C ^a,b   Lai, J L ^a,b   Bauters, F ^b   Fenaux, P ^a,b   Quesnel, B ^a,b  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

ALL; Immunocytochemistry; p16ink4a; Prognosis

Indexed keywords

HEMOGLOBIN; PROTEIN P16; PROTEIN P16INK4A;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CELL LINEAGE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; HEMOGLOBIN DETERMINATION; HOMOZYGOSITY; HUMAN; IMMUNOCYTOCHEMISTRY; KARYOTYPE; LEUKEMIA CELL; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STANDARD; T LYMPHOCYTE; ACUTE LYMPHOCYTIC LEUKEMIA; AGED; GENETICS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; METABOLISM; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENES, P16; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 0034742481     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402153     Document Type: Article

References (24)

1. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
2. p16ink4a gene and hematological malignancies
3. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia
4. Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia
5. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia
6. Expression of p16INK4A and p14ARF in hematological malignancies
7. Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas
8. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation
9. Mutations and altered expression of p16INK4 in human cancer
10. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ
11. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all morphologic subtypes: Potential prognostic implications
12. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
13. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation
14. p16 gene homozygous deletions in acute lymphoblastic leukemia
15. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features
16. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome
17. Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: Results of St Jude Total Therapy Study XII
18. Incidence and clinical significance of CDKN2/MTS1/P16ink4A and MTS2/P15ink4B gene deletions in childhood acute lymphoblastic leukemia
19. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia
20. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group
21. Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia
22. Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood
23. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies
24. Acquisition of p16(INK4A) and p15(INK4B) gene abnormalities between initial diagnosis and relapse in children with acute lymphoblastic leukemia